Trichomoniasis, chlamydia, and gonorrhea are the three most prevalent, treatable STDs in the U.S. If left untreated, complications can include infertility, pelvic inflammatory disease, pregnancy complications, and increased risk of HIV acquisition.
1CDC recommends:
1- Annual CT/NG screening of all sexually active women under 25
- Screening of other at-risk individuals including MSM*
- Testing for chlamydia, gonorrhea, & trichomoniasis using NAATs^ (PCR)
- Timely testing and treatment
* STD — Sexually Transmitted Diseases
^ NAAT — Nucleic Acid Amplification Test
# PrEP — Pre-Exposure Prophylaxis
(1) 2015 European Guideline on the Management of Chlamydia Trachomatis Infections. Euro Surveill. 2015;20(48):30080.
(2) WHO Guidelines for the Treatment of Chlamydia Trachomatis. Accessed Jun 2020. https://apps.who.int/iris/bitstream/handle/10665/246165/9789241549714-eng.pdf?sequence=1
(3) WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Accessed Jun 2020. https://apps.who.int/iris/bitstream/handle/10665/246114/9789241549691-eng.pdf?sequence=1
(4) 2012 European Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults. Int J STD AIDS. 2013 Feb;24(2):85-92.
(5)BHIVA/BASHH Guidelines on the Use of HIV Pre-Exposure Prophylaxis (PrEP) 2018. HIV Med. 2019 Mar;20 Suppl 2:s2-s80.